TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
CGEN

Compugen

Healthcare · Biotechnology

2.40$ +0.9% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow CGEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – -36.2%
– +68.1% +34.2% +7.3% -12.5% -29.1% -27.7% -35.5% +4.6% -1.2% +2.1% -2.3%
– +3.9% -18.3% -14.6% -17.7% +11.2% +15.1% +54.3% +1.2% -18.0% -14.8% -37.8%
– +116.6% -8.8% -7.2% -12.9% -0.6% +30.8% +41.7% +2.1% – – –
– – – -70.1% +155.1% -167.1% – – -181.4% – – -108.6%
– +64.6% -16.7% -85.2% -59.0% -1.9% +7.1% +75.9% +66.8% -64.7% -31.4% +159.3%
– – +66.8% +184.0% -176.0% – -1,641.7% – +460.2% -4.2% -230.3% –
– -98.7% +152.9% -91.8% +14,027.4% -8.7% – – – – – –
– -98.7% +152.9% -91.8% +14,027.4% -8.7% +318.3% -84.5% -97.9% +772.8% -82.0% +1,814.1%
– – – – -226.8% – -160.2% – +312.9% -2.5% +40.2% +1,721.0%
– – – – – – – – – – – -36.7%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?